• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Blog
  • News & Events
  • Videos
  • Resources
main-logo-small

Compliance Architects

Consulting Technology Outsourcing

  • About Us
    • Senior Staff
    • Why Us
    • Mission And Vision
    • Clients
    • Partners
    • Career Opportunities
  • Services
    • Inspection Readiness & Enforcement
      • FDA Inspection Readiness
      • Audits & Assessments
      • FDA Enforcement Response/Remediation
    • FDA Quality Consulting
      • Quality System & Compliance Turnarounds / Restructuring
      • Training / Coaching
      • Quality & Compliance Computer-Based Systems
      • External Supply Chain Compliance
      • Part 11 & Computer Systems Validation
      • Turnkey Quality Systems
    • Quality Assurance and Engineering
      • CRPN Quality Roadmap®
      • Quality Culture Assessment
      • Product Quality Consulting
      • Operational Efficiency/Compliance Effectiveness
      • Project/Program Management
    • Corporate Compliance and Litigation
      • Corporate Compliance Programs
      • Interactions With Department Of Justice And The Courts
    • FDA Regulatory Consultants
      • Product Development / Submissions / Commercialization
      • REMS (Risk Evaluation And Mitigation Strategies)
      • Mergers / Acquisitions / Licensing
    • Quality, Compliance, Regulatory & Operations’ Staffing
      • Staffing
      • Talent Management
      • Rapid Turnaround
  • Innovative Solutions
    • Writing for Compliance®
    • CRPN Quality Roadmap®
    • Quality Pulse®
    • IEEP
    • REMS
  • Success Stories
  • Industries
    • Biopharmaceuticals
    • Cannabis/CBD
    • Cell & Gene Therapies
    • Combination Products
    • Cosmetics
    • Dietary Supplements
    • Medical Devices and Diagnostics
    • Pharmaceuticals
  • Contact Us
FDA Quality Agreements

What Should Companies Concentrate On When Partnering with CMOs and CDMOs?

The CDMO and CMO relationships and the whole kind of business dynamic is critically important to the life sciences space. And particularly now with what I what I see, and I think we’ve discussed, an explosion in the biopharmaceutical space. So, there’s a lot of amazing science that’s going on in the bio, the biologic space, the biopharmaceutical space, cell and gene therapy, there’s an explosion of science. The challenge is that, and I’ve said this before, is science is not a product. So, this you can have a great concept, you can have a great understanding of how the body reacts, and how you can reduce disease likelihood, or will reduce a disease state, but that’s entirely different from getting that conceptual science into a product. So, CDMOs are an essential component of a lot of these early-stage companies that are trying to commercialize this great science. So, that relationship is critically important.

The real reason that relationship is so important is because the sponsors, the companies who, you know, the science founders, the smaller companies, who have been creating this innovation, and the larger companies. By the way, there’s a lot of larger companies that use this. They need to own the intellectual property, they need to own the process going forward, they need to have knowledge. And so when you’re working with a partner so closely that is actually working on the development, working on the tech transfer, working on the manufacturing, there tends to be a lot of knowledge that is actually created but also flows into the CMO of CDMO.

So one of the things that is really one of the most important governing documents is what is typically called the “Quality Agreement.” And the Quality Agreement is really where they talk about you know “quality things.” They’re often negotiated separately. I’m not a big fan of that. Being an attorney, I look at agreements kind of in an integrated fashion. But, there are certainly reasons to look at commercial terms, and kind of scopes of work, separately from responsibilities for regulatory compliance, compliance generally, and some of the intellectual property considerations. Regardless, that agreement, you know, the portion that talks about roles and responsibilities, data information, oversight, governance, is critically important. And one of the things that we talk to companies about often is what I call operationalizing the Quality Agreement. So the agreement is a document. It’s a static document you kind of exists you know on its own. But how do you operationalize that? How do you create integration between the Sponsor and the CMO or CDMO? Because you really need the integration in a kind of a reciprocal information flow context, right? So the Sponsor needs to understand, and kind of be aligned, with what the CMO CDMO organization is doing with their development, with their you know, tech transfer, with their commercial production… and the company needs to keep the CDMO informed of any changes that are occurring from their perspective. You know, if it’s a commercial feedback loops from complaints, or MDRS, or whatever the case may be. So there needs to be a very tight integration. I call it an integration of the quality systems between the Sponsor companies and the CMOs CDMO’s. And I don’t think that’s often really done well. And I think that that is probably one of the things that I would recommend to companies if they if they don’t have an understanding how they how to do that, to get some help. Because the more tightly you can integrate the better.

Now, also, there are there is a lot going on with SaaS software. So, the digitization of information in the regulated space has created both opportunities and risks. So, let’s say we’re using a SaaS software, meaning cloud based software and you’ve got a CDMO that’s actually working on your product. Who owns that data? Do you own that data? Do they own that data? How do you do data transfers? How do you take that back in house? There are some real complicated situations that need to be thought through not only just from an intellectual property standpoint, but from a regulatory compliance standpoint, from a business standpoint. So, the leverage that CDMOs and CMOs give to companies is really important in this fast-moving industry when we’re trying to commercialize these great scientific breakthroughs, but there are definite risks, and a real focus needs to be put on that relationship definition, and the relationship governance, the integration points between the CDMO CMO and the Sponsor, it is critical. So, I that’s actually what I would say is a key area of concern, and companies really need to spend a lot of time on.

 

Taken from Executive Platforms 2022 Pharma Manufacturing World Summit. Click here to see the entire interview.

Filed Under: Achieving Compliance, Business, Quality Agreements, Quality Management & Assurance Tagged With: quality agreements;

Primary Sidebar

Sign Up To Our Newsletter

You May Also Like

Sue Soderholm to be a Featured Speaker at the 1st Annual Quality Management vSummit – “Optimizing Your Quality Management Program to Be Both World Class and FDA-Compliant” | Tuesday, October 11, 2022 – Wednesday, October 12, 2022

Achieve True Quality Culture and Stay Compliant If your quality management system (QMS) isn’t world class, you may be falling behind. You need the 1st Annual
life sciences staffing

Talk to us about current talent trends, and what the industry will need in the next 5 to 10 years?

Transcript taken from 2022 PMWS by Executive Platforms The talent crisis as it has been called is certainly not something that has gone away or

Preparing for an FDA Pre-Approval Inspection (PAI) – “Begin with the End in Mind.”

Presented by: Teresa Gorecki, Practice Lead, Compliance Architects What is it Steven Covey said in “The 7 Habits of Highly Effective People?” “Begin with the

Footer

Compliance Architects®

  • Contact Us
  • (888) 734-9778
  • info@compliancearchitects.com

Quick Links

  • About Us
    • Senior Staff
    • Why Us
    • Mission And Vision
    • Clients
    • Partners
    • Career Opportunities
  • Services
    • Inspection Readiness & Enforcement
      • FDA Inspection Readiness
      • Audits & Assessments
      • FDA Enforcement Response/Remediation
    • FDA Quality Consulting
      • Quality System & Compliance Turnarounds / Restructuring
      • Training / Coaching
      • Quality & Compliance Computer-Based Systems
      • External Supply Chain Compliance
      • Part 11 & Computer Systems Validation
      • Turnkey Quality Systems
    • Quality Assurance and Engineering
      • CRPN Quality Roadmap®
      • Quality Culture Assessment
      • Product Quality Consulting
      • Operational Efficiency/Compliance Effectiveness
      • Project/Program Management
    • Corporate Compliance and Litigation
      • Corporate Compliance Programs
      • Interactions With Department Of Justice And The Courts
    • FDA Regulatory Consultants
      • Product Development / Submissions / Commercialization
      • REMS (Risk Evaluation And Mitigation Strategies)
      • Mergers / Acquisitions / Licensing
    • Quality, Compliance, Regulatory & Operations’ Staffing
      • Staffing
      • Talent Management
      • Rapid Turnaround
  • Innovative Solutions
    • Writing for Compliance®
    • CRPN Quality Roadmap®
    • Quality Pulse®
    • IEEP
    • REMS
  • Success Stories
  • Industries
    • Biopharmaceuticals
    • Cannabis/CBD
    • Cell & Gene Therapies
    • Combination Products
    • Cosmetics
    • Dietary Supplements
    • Medical Devices and Diagnostics
    • Pharmaceuticals
  • Contact Us

Our Services

  • Inspection Readiness & Enforcement
  • FDA Quality Consulting – Systems and Training
  • Quality Assurance and Engineering
  • Corporate Compliance and Litigation Services
  • FDA Regulatory Consultants – Due Diligence
  • Quality, Compliance, Regulatory & Operations’ Staffing Services

Proprietary Solutions

  • Writing for Compliance®
  • Quality Pulse®
  • CRPN Quality Roadmap®

© 2009-2023 Compliance Architects Holdings LLC – used by permission. All copyrights, trademarks and other intellectual property are the property of Compliance Architects Holdings LLC and are used by permission.

  • Debarment Certification Statement
  • Privacy Policy
  • Terms of Use

Contact Us Today

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
Cookie SettingsAccept
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT